Flyte.bio – Investor Strategy Partner for Early-Stage Biotech

Early-Stage Biotech Growth Partner

We map your competitive landscape, score and rank the investors most likely to fund you, and build the materials that get you in the room — all powered by HOUSTON, our proprietary biotech intelligence platform.

Competitive Landscapes

Investment Firm Alignment

Partnership Mapping

Big Pharma Analysis

Exit Strategy & Intelligence

Full Biotech Branding

What FLYTE Delivers

We help with everything a builder in early-stage biotech needs to raise smarter, partner faster, and position for exit.

Competitive Landscapes

Know every company in your space — by mechanism, modality, and stage. See where the white space is.

Investor Alignment

Aligned, scored and ranked investor lists based on real portfolio data and firm preferences – never “shots in the dark”.

Partnership Mapping

CDMOs, diagnostics, bio-tools — scored and matched to your development needs and clinical strategy.

Big Pharma Analysis

Identify which acquirers have pipeline gaps you fill. Acquisition patterns, deal values, and strategic fit.

Exit Precedents

Validated exit paths in your space — who got acquired, at what stage, and what it means for your timeline.

Full Biotech Branding

We turn your alignment intelligence into a company deck and website that speak to the people writing checks.

The Workflow: An Overview

After a short 30-min onboarding call, we deliver everything to you within 48 hours.

STEP 1

Discovery call

We learn your science, your stage, and your current goals. 30 minutes, no commitment.

STEP 2

HOUSTON Alignment

We run your company through our proprietary intelligence platform — mapping competitors, scoring investors, and identifying strategic partners across the entire biotech ecosystem.

STEP 3

Your Playbook

You get a full Alignment Breakdown based on your goals: ranked investor targets, competitive positioning, partnership opportunities, investor-ready outreach materials, and more.

Who We Work With

Same proprietary intelligence. Different strategic problems.

Early-Stage Therapeutics

Preclinical through Series A

“We have strong science but no idea who to pitch, how we compare, or where we fit in the landscape.”

What we solve:

Competitive positioning · Investor targeting & ranking · Outreach materials · White space identification · Partnership mapping

MOST COMMON

Bio-Tools & Services

Research platforms, and enabling technologies

“We know our technology works, but we don’t know who our customers are, how to reach them, or how we stack up against competitors.”

What we solve:

Customer identification & ranking · Competitive positioning · Investor targeting · Partnership mapping · Outreach strategy · Websites, decks & collateral

Growth-Stage Biotechs

Series B+ and pipeline expansion

“We need to understand our competitive landscape as we expand indications, and start positioning for pharma partnerships or acquisition.”

What we solve:

Pipeline expansion CI · Big pharma acquirer mapping · Licensing & partnership alignment · Exit precedent analysis

Universities & TTOs

Tech transfer, incubators, accelerators

“We have dozens of spinouts at various stages and no way to prioritize which ones are investible or map their competitive positions.”

What we solve:

Spinout classification & prioritization · Competitive positioning per asset · Investor landscape mapping · Portfolio-level intelligence

Fill out a 2-minute form and we’ll send you a custom briefing on how FLYTE can support your current goals — no call required.